TBVI Governance Board Communiqué Tuberculosis (TB) is a major unsolved global health problem. Novel vaccines against TB will be critical tools to ultimately end this silent pandemic. TBVI and its [...]
From 15-18 May 2023, the first annual progress meeting of the MTBVAC phase III clinical trial EDCTP co-funded project took place in Andasibe and Antananarivo, Madagascar. The consortium, composed [...]
The Horizon Europe programme has funded the ITHEMYC project to establish a critical path for selection of promising innovative adjunct TB immunotherapies and progress 2 of these immunotherapies [...]
The Horizon Europe programme has funded the TBVAC-HORIZON project to improve the understanding of lung immunity to tuberculosis infection and to establish a diversified innovative TB vaccine [...]
The four EDCTP-funded late-stage TB vaccine development projects: POR TB Consortium, priMe and MTBVAC-Newborns Phase 2a and MTBVACN3, meet on a regular basis to exchange knowledge and [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
